__NUXT_JSONP__("/drugs/P-cadherin-targeting_Agent_PF-06671008", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An agent that targets p-cadherin (CDH3), with potential antineoplastic activity. Upon administration, PF-06671008 binds to and inhibits the activity of p-cadherin; this may inhibit both invasion and proliferation of p-cadherin expressing tumor cells. P-cadherin, a cell-surface protein and member of the cadherin family, is overexpressed in a variety of tumors and plays a role in cell adhesion, motility, invasion, and proliferation.",fdaUniiCode:"2GWZ8HN70W",identifier:"C125607",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C177279"],synonyms:[c,"PF-06671008"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FP-cadherin-targeting_Agent_PF-06671008",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","P-cadherin-targeting_Agent_PF-06671008","P-cadherin-targeting Agent PF-06671008","2021-10-30T13:30:33.823Z")));